Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RR00646
Host Cell : LN229 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RR00646 |
| Description | LN-229-GFP reporter cell line is engineered to stably express GFP reporter gene in LN-229 cell line. |
| Target Gene | GFP |
| Host Cell | LN229 |
| Host Cell Species | Homo sapiens (Human) |
| Applications |
1. Gene expression studies 2. Protein localization 3. Drug screening and toxicology 4. Live cell imaging |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Target Gene | GFP |
LN-229 is a well-established human glioblastoma cell line derived from a malignant brain tumor and is widely used as an in vitro model for studying glioma biology, tumor progression, and therapeutic response. The cells typically grow as an adherent monolayer with a fibroblast-like to polygonal morphology and are known for their relevance to high-grade glioma research, including investigations of cell proliferation, migration, invasion, apoptosis, DNA damage response, and oncogenic signaling. GFP Reporter Cell Line - LN-229 is a derivative of the parental LN-229 cell line that has been engineered to stably express green fluorescent protein, allowing the cells to be directly visualized and quantified by fluorescence-based methods. The stable GFP signal provides a convenient, non-destructive readout for tracking viable cells over time without the need for additional staining in many experimental settings.
GFP Reporter Cell Line - LN-229 is particularly useful for applications requiring sensitive visualization, tracking, and quantification of glioblastoma cells. In cancer biology research, it can be used to monitor tumor cell growth, clonogenic expansion, drug response, and cytotoxicity in fluorescence microscopy, live-cell imaging, flow cytometry, high-content screening, and plate-based fluorescence assays. The GFP label makes it easier to distinguish LN-229 tumor cells from non-fluorescent stromal cells, immune cells, endothelial cells, astrocytes, or extracellular matrix components in co-culture systems, thereby supporting studies of tumor microenvironment interactions. In migration and invasion assays, including wound-healing, transwell, spheroid invasion, and three-dimensional matrix models, GFP fluorescence enables dynamic observation of cell movement and spatial distribution.
Glioblastoma multiforme (GBM) is a deadly malignant tumor characterized by the diffuse invasion of tumor cells into the surrounding brain parenchyma. However, the diffusion characteristics of GBM and its relationship with the tumor microenvironment (TME) remain unclear. Here, researchers investigated the interaction between GBM and its surrounding microenvironment using two human glioma cell lines, U87 and LN229, in an orthotopic xenograft animal model. GBM cells exhibited different characteristics in terms of cell growth rate during development, diffusion characteristics of glioma cells along blood vessels, and invasion of the brain parenchyma. Their results suggest that these differences between the two models are partly attributed to differences in the expression of CXCR4 and STAT3, both of which play important roles in tumor progression. Furthermore, GBM showed a large aggregation of intrinsic microglia and peripheral macrophages, but its polarization toward tumor-supporting cells differed. These results indicate that intrinsic factors of GBM and its interaction with the TME determine the diffusion characteristics and potential reactivity of non-cancerous cells within the TME.
Perivascular growth is the most common feature of glioblastoma (GBM), resulting from the migration and distribution of GBM cells near endothelial cells. Brain tissue is divided into 1 to 4 regions from the tumor inoculation site to the ventral surface of the brain: intratumoral region (region 1), tumor-associated boundary (region 2), and distal regions (regions 3 and 4) (Figure 1A). HE staining showed that U87/GFP cells had a clear boundary between regions 2 and 3, while the boundary of LN229/GFP cells was more diffuse. To determine whether the clear boundary of U87/GFP cells and the diffuse distribution of LN229/GFP cells were due to their intrinsic tropism towards blood vessels, researchers stained brain tissue sections from U87/GFP and LN229/GFP xenografts with a specific antibody against the endothelial cell marker CD-31. U87/GFP cells coexisted with blood vessels in regions 1 and 2, but were rare in regions 3 and 4. Clearly, U87/GFP cells were closely associated with CD-31-positive blood vessels in region 3. In contrast, LN229/GFP cells were not only visible in regions 1 and 2, but also abundant in regions 3 and 4 (Figure 1B and C). LN229/GFP cells were found to be associated with blood vessels in all regions (indicated by arrows in Figure 1D). These results suggest that LN229 cells grow at a lower rate than U87 cells, but their infiltration and diffusion are more extensive.
Figure 1. Distinct distribution of GBM around the tumor center. (Han J, et al., 2020)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
LN-229 GFP cells from Creative Biogene gave me clear, stable fluorescence throughout my neuro-oncology assays. Their growth characteristics matched published data exactly—no surprises, just reliable performance every time.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.